RecruitingNCT07594717

Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder

Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder Receiving Buprenorphine


Sponsor

Prisma Health-Upstate

Enrollment

70 participants

Start Date

Nov 12, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study examines the effects of e-cigarette (EC) flavors among adults with opioid use disorder (OUD) receiving buprenorphine treatment who currently use e-cigarettes. Participants will smell and rate 11 EC flavors based on appeal, sensory characteristics, and likelihood of future use. Researchers will examine how different flavor profiles influence the appeal and reinforcing effects of ECs in this population. The goal is to identify EC flavors that may enhance the acceptability of ECs as a potential harm-reduction strategy among adults with OUD receiving buprenorphine treatment.


Eligibility

Min Age: 21 Years

Inclusion Criteria5

  • Adults aged 21 years or older.
  • Current e-cigarette users who report e-cigarette use on ≥20 of the past 30 days.
  • Former daily cigarette smokers who currently smoke on ≤19 days per month and no more than 5 cigarettes per day.
  • Diagnosed with opioid use disorder (OUD).
  • Currently receiving buprenorphine treatment for OUD.

Exclusion Criteria1

  • \-

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGSweet-cooling

Sweet-cooling EC flavor

DRUGSweet non-cooling EC flavor

Sweet non-cooling flavor

DRUGTobacco flavor EC

Tobacco flavor EC


Locations(1)

Prisma Health Recovery Clinic-Greenville

Greenville, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07594717


Related Trials